Morten Grauslund

4PUBLICATIONS
9CO-AUTHORS
Gene and molecular therapyMedical biotechnology diagnostics (incl. biosensors)Solid tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 11, 2026
Targeting MET amplification in non-small cell lung cancer: encouraging results with vebreltinib from the phase II KUNPENG study.

|Jan 10, 2026
Improvement of Diagnostics in NSCLC Patients with MET Exon 14 Mutations Using Complementary DNA/RNA-NGS and Identification of Two Novel Exonic Splicing Mutations.

Edyta Maria Urbanska, Thomas Koed Doktor, Linea Cecilie Melchior

|Jul 12, 2025
Refining Criteria for Choosing the First-Line Treatment for Real-World Patients with Advanced ALK-Rearranged NSCLC.

Edyta Maria Urbanska, Peter Rindom Koffeldt, Morten Grauslund

|Oct 21, 2024
ALK-tyrosine kinase inhibitor intrinsic resistance due to de novo MET-amplification in metastatic ALK-rearranged non-small cell lung cancer effectively treated by alectinib-crizotinib combination-case report.

Edyta M Urbanska, Morten Grauslund, Siv M S Berger

Pageof 1

Frequent Collaborators

4 joint publications

Edyta Maria Urbanska

4 joint publications

Jens Benn Sørensen

4 joint publications

Eric Santoni-Rugiu

2 joint publications

Peter Rindom Koffeldt